More details on this developing story will follow.
Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study - Slideshow
By Dhallo News · September 5, 2026 at 4:38 AM IST
SOURCE: Seeking Alpha - Stock Ideas
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion
